 Connection
Marilyn Manco-Johnson to Antiphospholipid Syndrome
This is a "connection" page, showing publications Marilyn Manco-Johnson has written about Antiphospholipid Syndrome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.517 |
|
|
|
-
Manco-Johnson MJ. Risk of stratified therapies for antiphospholipid antibody syndrome (APS) in pregnancy: is tailored treatment ready for prime time? J Thromb Haemost. 2005 Feb; 3(2):240-2.
Score: 0.214
-
Manco-Johnson MJ, Wang M, Goldenberg NA, Soep J, Gibson E, Knoll CM, Mourani PM. Treatment, survival, and thromboembolic outcomes of thrombotic storm in children. J Pediatr. 2012 Oct; 161(4):682-8.e1.
Score: 0.089
-
Kenet G, Aronis S, Berkun Y, Bonduel M, Chan A, Goldenberg NA, Holzhauer S, Iorio A, Journeycake J, Junker R, Male C, Manco-Johnson M, Massicotte P, Mesters R, Monagle P, van Ommen H, Rafini L, Simioni P, Young G, Nowak-Göttl U. Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis. Semin Thromb Hemost. 2011 Oct; 37(7):802-9.
Score: 0.086
-
Goldenberg NA, Tripputi M, Crowther M, Abshire TC, DiMichele D, Manco-Johnson MJ, Hiatt WR. The "parallel-cohort RCT": Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism. Contemp Clin Trials. 2010 Jan; 31(1):131-3.
Score: 0.075
-
Manco-Johnson MJ. Etiopathogenesis of pediatric thrombosis. Hematology. 2005; 10 Suppl 1:167-70.
Score: 0.053
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|